NASDAQ / LIVE COMPANY INTELLIGENCE

Maravai LifeSciences Holdings, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERMRVI
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / MRVI COVERAGE

What’s moving Maravai LifeSciences Holdings, Inc. now

Current reporting with the operating signal separated from the noise.

01
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Investors are testing whether Maravai LifeSciences Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript

Investors are testing whether Maravai LifeSciences Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates

Investors are testing whether Maravai LifeSciences Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management?

Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management?

Investors are testing whether Maravai LifeSciences Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – MRVI

Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations

The development tests whether Maravai LifeSciences Holdings, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
06
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights – MRVI

Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights – MRVI

The development tests whether Maravai LifeSciences Holdings, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
07
MRVI

Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights

The development tests whether Maravai LifeSciences Holdings, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
08
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

The development tests whether Maravai LifeSciences Holdings, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest MRVI filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-08 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-07 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-03 · Period 2026-06-02SEC ↗8-KMaterial company eventFiled 2026-05-29 · Period 2026-05-26SEC ↗8-KMaterial company eventFiled 2026-05-07 · Period 2026-05-07SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-24 · Period 2026-05-26SEC ↗4Official SEC filingFiled 2026-08-03 · Period 2026-07-30SEC ↗
EARNINGS / QUARTERLY TRACKER

Maravai LifeSciences Holdings, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.